DJ Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bristol Myers Squibb Co. $(BMY)$ shed 2.46% to $56.70 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.72% to 7,537.43 and the Dow Jones Industrial Average rising 0.29% to 53,055.91.

Bristol Myers Squibb Co. closed 9.84% below its 52-week high of $62.89, which the company reached on March 2nd.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 1.41% to $259.33, Pfizer Inc. $(PFE)$ fell 2.47% to $23.72, and Abbott Laboratories $(ABT)$ rose 0.24% to $95.63.

Trading volume (9.0 M) remained 3.1 million below its 50-day average volume of 12.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 6, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

July 06, 2026 16:38 ET (20:38 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.